BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 32929994)

  • 1. Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR.
    Biotechniques; 2020 Sep; 69(3):237. PubMed ID: 32929994
    [No Abstract]   [Full Text] [Related]  

  • 2. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 3. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 Sep; 16(706):1726. PubMed ID: 32936565
    [No Abstract]   [Full Text] [Related]  

  • 5. Spit shines for easier coronavirus testing.
    Service RF
    Science; 2020 Aug; 369(6507):1041-1042. PubMed ID: 32855317
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.
    Fukumoto T; Iwasaki S; Fujisawa S; Hayasaka K; Sato K; Oguri S; Taki K; Nakakubo S; Kamada K; Yamashita Y; Konno S; Nishida M; Sugita J; Teshima T
    Int J Infect Dis; 2020 Sep; 98():16-17. PubMed ID: 32599282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits.
    Chu AW; Chan WM; Ip JD; Yip CC; Chan JF; Yuen KY; To KK
    J Clin Virol; 2020 Aug; 129():104519. PubMed ID: 32629187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empowering academic labs and scientists to test for COVID-19.
    Steel JJ; Sitko JC; Adkins MG; Hasstedt SC; Rohrer JW; Almand EA
    Biotechniques; 2020 Oct; 69(4):245-248. PubMed ID: 32584188
    [No Abstract]   [Full Text] [Related]  

  • 10. A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring.
    Tajima Y; Suda Y; Yano K
    J Infect Chemother; 2020 Oct; 26(10):1086-1089. PubMed ID: 32571647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis.
    Byrne RL; Kay GA; Kontogianni K; Aljayyoussi G; Brown L; Collins AM; Cuevas LE; Ferreira DM; Fraser AJ; Garrod G; Hill H; Hughes GL; Menzies S; Mitsi E; Owen SI; Patterson EI; Williams CT; Hyder-Wright A; Adams ER; Cubas-Atienzar AI
    Emerg Infect Dis; 2020 Nov; 26(11):2770-2771. PubMed ID: 32917294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.
    Kochhar AS; Bhasin R; Kochhar GK; Dadlani H
    Oral Oncol; 2020 Aug; 107():104813. PubMed ID: 32471801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.
    Lambert-Niclot S; Cuffel A; Le Pape S; Vauloup-Fellous C; Morand-Joubert L; Roque-Afonso AM; Le Goff J; Delaugerre C
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32404480
    [No Abstract]   [Full Text] [Related]  

  • 15. My Experience with SARS-CoV-2, with a Focus on Testing.
    Cotter PA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 63 days detection of SARS-CoV-2 RNA from a recovered patient in Southern Italy: A Case Report.
    Baldacci S; Giannico OV; Giorgino A; Buccoliero GB; Desiante F; Fragnelli GR; Rizzi R; Loconsole D; Centrone F; Chironna M; Conversano M
    Ann Ig; 2020; 32(5):590-592. PubMed ID: 32744589
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
    Chen JH; Yip CC; Poon RW; Chan KH; Cheng VC; Hung IF; Chan JF; Yuen KY; To KK
    Emerg Microbes Infect; 2020 Dec; 9(1):1356-1359. PubMed ID: 32459137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting Diagnostic Tests for SARS-CoV-2.
    Sethuraman N; Jeremiah SS; Ryo A
    JAMA; 2020 Jun; 323(22):2249-2251. PubMed ID: 32374370
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19.
    Sakanashi D; Asai N; Nakamura A; Miyazaki N; Kawamoto Y; Ohno T; Yamada A; Koita I; Suematsu H; Hagihara M; Shiota A; Kurumiya A; Sakata M; Kato S; Muramatsu Y; Koizumi Y; Kishino T; Ohashi W; Yamagishi Y; Mikamo H
    J Infect Chemother; 2021 Jan; 27(1):126-129. PubMed ID: 33060046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
    Hogan CA; Sahoo MK; Huang C; Garamani N; Stevens B; Zehnder J; Pinsky BA
    J Clin Virol; 2020 Jul; 128():104410. PubMed ID: 32403009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.